SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-037539
Filing Date
2020-11-17
Accepted
2020-11-17 08:00:47
Documents
2
Period of Report
2020-11-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea130055-8k_180lifescience.htm 8-K 24009
2 PRESS RELEASE DATED NOVEMBER 17, 2020 ea130055ex99-1_180life.htm EX-99.1 29640
  Complete submission text file 0001213900-20-037539.txt   54837
Mailing Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019
Business Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019 212-319-5555
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 201319277
SIC: 2834 Pharmaceutical Preparations